Abstract
A physician’s guiding principle is “First, do no harm.” As a result, new treatments for diseases must be tested thoroughly, preferably in double-blind, placebo-controlled, randomized clinical trials, before they can be approved and then prescribed to patients. For trial results to be considered statistically significant, a large number of study participants are needed, and typically recruiting enough participants with a given disease or with susceptibility to the disease is difficult. Progress in translating research into clinical treatments is slower than it could be because of this bottleneck in the process of conducting clinical trials.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2015 Allen G. Taylor
About this chapter
Cite this chapter
Taylor, A.G. (2015). The ResearchKit Health Projects. In: Get Fit with Apple Watch. Apress, Berkeley, CA. https://doi.org/10.1007/978-1-4842-1281-3_8
Download citation
DOI: https://doi.org/10.1007/978-1-4842-1281-3_8
Publisher Name: Apress, Berkeley, CA
Print ISBN: 978-1-4842-1282-0
Online ISBN: 978-1-4842-1281-3
eBook Packages: Professional and Applied ComputingApress Access BooksProfessional and Applied Computing (R0)